The CDR3 Region: A Pivotal Player in Antigen Recognition
The CDR3 region of antibodies plays a particularly pivotal role in the immune system's ability to combat pathogens.
Checkpoint inhibitors are a form of immunotherapy used to treat cancer.
The CDR3 region of antibodies plays a particularly pivotal role in the immune system's ability to combat pathogens.
The immune system is responsible for defending the body against harmful microorganisms, foreign bodies, and dangerous substances.
Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) prevents overactivation of the immune system and averts potential damage to the body's own cells.